Summary by Moomoo AI
On December 13, 2024, Shanghai FOSUN PHARMA (Group) Co., Ltd. repurchased 185,500 H shares on the Hong Kong Stock Exchange as treasury shares. The repurchase price range was HKD 14.30 to HKD 14.46 per share, with a total value of approximately HKD 2.6635 million.This repurchase accounted for 0.03% of the total H shares of the company. After the repurchase, the total number of H shares decreased from 545,300,500 shares to 545,115,000 shares, and the number of treasury shares increased to 6,825,500 shares. The total share capital of the company remains unchanged at 551,940,500 shares.According to the authorization from the shareholders' meeting on June 26, 2024, the company may repurchase up to 55,194,050 H shares. As of this repurchase, the company has cumulatively repurchased 6,825,500 shares, accounting for 12.37% of the authorized limit. According to regulations, the company cannot issue new shares or sell treasury shares within 30 days after this repurchase.
